SCHEMBL561739

SCHEMBL561739

CCCCCCCCCCCCCCCCCC(F)(C=C(C)C(=O)O)CCCCCCCCC

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.46
LPAR1 Q92633 1/20 0.42
LPAR3 Q9UBY5 1/20 0.42
FAAH O00519 9/20 0.40
CES1 P23141 6/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
EP300 Q09472 1/20 0.39
THRB P10828 1/20 0.38
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
PGGT1B P53609 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9418790 1.00 CES2 (0.46) CES2LPAR1LPAR3FAAHCES1
SCHEMBL10430508 1.00 CES2 (0.46) CES2LPAR1LPAR3FAAHCES1
SCHEMBL15791892 0.80 EP300 (0.40) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL15577114 0.80 CES2 (0.43) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL15791978 0.80 EP300 (0.40) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL1286855 0.79 EP300 (0.38) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL1286854 0.79 EP300 (0.38) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL5856231 0.78 EP300 (0.37) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL8366244 0.76 FDPS (0.36) CES2MEN1KMT2AHSD17B10EP300
SCHEMBL7029249 0.76 CES2 (0.37) CES2LPAR1LPAR3FAAHCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563273-B1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEV LLC (US) 2017-08-23 EP claimed
US-9539087-B2 Intravitreous self adaptive stent EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-10 US claimed
EP-2563273-A1 INTRAVITREOUS SELF ADAPTIVE STENT Empire Technology Development LLC (US) 2013-03-06 EP claimed
US-20120035738-A1 INTRAVITREOUS SELF ADAPTIVE STENT CRESTLINE DIRECT FINANCE, L.P. 2012-02-09 US claimed
WO-2011134146-A1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2011-11-03 WO claimed
US-20040059408-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2004-03-25 US claimed
US-6653426-B2 Radially expandable; coaxial polymer comprising pentafluoropropyl acrylate and (heptadecyl fluorodecyl methacrylate) comonomers QUANAM MEDICAL CORPORATION 2003-11-25 US claimed
US-20030149470-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2003-08-07 US claimed
US-6530950-B1 Radially expandable; rigid and flexible regions; polymer of such as pentafluoropropyl acrylate, polyethylene glycol methacrylate and methylmethacrylate QUANAM MEDICAL CORPORATION 2003-03-11 US claimed
EP-1140242-B1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORP (US) 2002-10-30 EP claimed
EP-1140242-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT Quanam Medical Corporation (US) 2001-10-10 EP claimed
EP-0818479-B1 Polymeric surface coatings BIOCOMPATIBLES LTD (GB) 2000-09-13 EP claimed
WO-2000041738-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORPORATION (US) 2000-07-20 WO claimed
US-5739236-A FOR ATTACHING LIGANDS TO POLYMER WHEN COATED ON A SURFACE BIOCOMPATIBLES LIMITED (GB) 1998-04-14 US claimed
EP-0818479-A2 Polymeric surface coatings BIOCOMPATIBLES LIMITED (GB) 1998-01-14 EP claimed
EP-2563273-B1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEV LLC (US) 2017-08-23 EP disclosed
US-9539087-B2 Intravitreous self adaptive stent EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-10 US disclosed
EP-1140242-B1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORP (US) 2002-10-30 EP disclosed
EP-1140242-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT Quanam Medical Corporation (US) 2001-10-10 EP disclosed
WO-2000041738-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORPORATION (US) 2000-07-20 WO disclosed